Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$0.22 - $0.4 $24,542 - $44,622
111,557 Added 23.48%
586,727 $140,000
Q4 2022

Feb 13, 2023

SELL
$0.6 - $17.32 $19,485 - $562,484
-32,476 Reduced 6.4%
475,170 $363,000
Q3 2022

Nov 14, 2022

BUY
$0.8 - $15.88 $14,776 - $293,303
18,470 Added 3.78%
507,646 $396,000
Q2 2022

Aug 12, 2022

SELL
$1.18 - $2.04 $751,402 - $1.3 Million
-636,782 Reduced 56.55%
489,176 $836,000
Q1 2022

May 13, 2022

BUY
$1.34 - $2.26 $197,296 - $332,753
147,236 Added 15.04%
1,125,958 $2.11 Million
Q4 2021

Feb 11, 2022

SELL
$2.1 - $4.36 $114,561 - $237,851
-54,553 Reduced 5.28%
978,722 $2.06 Million
Q3 2021

Nov 12, 2021

BUY
$3.9 - $5.67 $340,321 - $494,775
87,262 Added 9.22%
1,033,275 $4.21 Million
Q2 2021

Aug 13, 2021

BUY
$4.85 - $6.9 $2.17 Million - $3.09 Million
448,123 Added 90.0%
946,013 $5.07 Million
Q1 2021

May 12, 2021

BUY
$6.09 - $12.2 $1.69 Million - $3.39 Million
277,799 Added 126.22%
497,890 $3.34 Million
Q4 2020

Feb 12, 2021

BUY
$3.56 - $10.21 $428,243 - $1.23 Million
120,293 Added 120.54%
220,091 $1.93 Million
Q3 2020

Nov 13, 2020

BUY
$2.49 - $5.16 $60,004 - $124,345
24,098 Added 31.83%
99,798 $447,000
Q1 2020

May 14, 2020

BUY
$1.52 - $2.66 $3,316 - $5,804
2,182 Added 2.97%
75,700 $123,000
Q3 2019

Nov 12, 2019

BUY
$2.5 - $3.93 $39,950 - $62,801
15,980 Added 27.77%
73,518 $183,000
Q1 2019

May 14, 2019

BUY
$2.11 - $4.89 $50,125 - $116,166
23,756 Added 70.32%
57,538 $126,000
Q2 2018

Aug 14, 2018

BUY
$2.82 - $3.49 $95,265 - $117,899
33,782 New
33,782 $112,000

Others Institutions Holding AQB

About AquaBounty Technologies, Inc.


  • Ticker AQB
  • Exchange NASDAQ
  • Sector Consumer Defensive
  • Industry Farm Products
  • Shares Outstandng 71,110,704
  • Market Cap $84.6M
  • Description
  • AquaBounty Technologies, Inc., a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sel...
More about AQB
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.